BloodScan Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 3

BloodScan General Information

Description

Developer of circulating tumor cell diagnostics designed to enable earlier noninvasive cancer detection. The company offers circulating tumor cell isolation technology, blood-based cancer testing, automated cell separation systems, genomic analysis support, histology-ready cell collection, cancer diagnostic services, and laboratory platforms for tumor detection and characterization, enabling healthcare providers to obtain cancer-related diagnostic insights through blood samples and generate treatment-relevant tumor information when tissue sampling is difficult or unavailable.

Contact Information

Website
www.bloodscanbiotech.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • North Campus Research Complex (NCRC)
  • Building 20, Rooms 301-314 West 2800 Plymouth Road
  • Ann Arbor, MI 48109-2800
  • United States
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • North Campus Research Complex (NCRC)
  • Building 20, Rooms 301-314 West 2800 Plymouth Road
  • Ann Arbor, MI 48109-2800
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BloodScan Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 08-Apr-2026 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. University Spin-Out 01-Jan-2023 Completed Generating Revenue
To view BloodScan’s complete valuation and funding history, request access »

BloodScan Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
UC Berkeley School of Public Health Innovation Accelerator Program Accelerator/Incubator
University of Michigan University
Innovation Partnerships Venture Capital Minority
To view BloodScan’s complete investors history, request access »

Ready to get started?

Request a free trial

BloodScan FAQs

  • When was BloodScan founded?

    BloodScan was founded in 2023.

  • Where is BloodScan headquartered?

    BloodScan is headquartered in Ann Arbor, MI.

  • What industry is BloodScan in?

    BloodScan’s primary industry is Diagnostic Equipment.

  • Is BloodScan a private or public company?

    BloodScan is a Private company.

  • What is BloodScan’s current revenue?

    The current revenue for BloodScan is .

  • Who are BloodScan’s investors?

    UC Berkeley School of Public Health Innovation Accelerator Program, University of Michigan, and Innovation Partnerships have invested in BloodScan.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process